Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Capital Expenditures (2016 - 2025)

CorMedix has reported Capital Expenditures over the past 12 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $1.7 million for Q4 2025, up 16865.22% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (up 1848.28% YoY), and the annual figure for FY2025 was $2.3 million, up 1848.28%.
  • Capital Expenditures reached $1.7 million in Q4 2025 per CRMD's latest filing, up from $505774.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.7 million in Q4 2025 and bottomed at $4324.0 in Q1 2022.
  • Median Capital Expenditures over the past 5 years was $19355.5 (2023), compared with a mean of $217399.4.
  • The largest annual shift saw Capital Expenditures crashed 96.57% in 2024 before it surged 16865.22% in 2025.
  • Over 5 years, Capital Expenditures stood at $628761.0 in 2021, then crashed by 79.52% to $128755.0 in 2022, then skyrocketed by 129.84% to $295931.0 in 2023, then plummeted by 96.57% to $10139.0 in 2024, then soared by 16865.22% to $1.7 million in 2025.
  • Business Quant data shows Capital Expenditures for CRMD at $1.7 million in Q4 2025, $505774.0 in Q3 2025, and $23945.0 in Q2 2025.